Regulatory updates, compliance insights, and industry analysis from the ACPL team.
Entering the Indian Pharmaceutical Market: A Practical Guide for European Pharma Companies India’s pharmaceutical market is massive, but it’s not…
Read MoreMeat, poultry and seafood businesses face tighter FSSAI scrutiny in 2026 — new turnover thresholds, a sausage-standard deadline, and zero…
Read More
CPCB just made life easier for anyone managing EPR accounts with their new “Lost Credentials” feature. If you’re stuck because…
Read More
CDSCO Issues Guidance for Importing and Marketing Globally Unapproved New Drugs After Phase III Trials On August 10, 2026, the…
Read More
Why Your BIS Certification Application Gets Rejected—and What You Can Do About It Getting BIS Certification isn’t just another box…
Read MoreCDSCO has floated a tender to build a next-gen Digital Drugs Regulatory System while SUGAM adds new modules. Here's what…
Read More
India’s Central Drugs Standard Control Organization (CDSCO) just rolled out a new Guidance Document for importing and registering drugs—both bulk…
Read More
Biological Products Licenses and Approvals in India: Your Guide to the CDSCO Process by ACPL Group India – Regulatory Affairs…
Read MoreFSSAI has scrapped mandatory BIS certification for packaged drinking water and replaced it with a strict new testing regime from…
Read More
Importing medical devices into India isn’t simple—it’s tightly regulated by the Central Drugs Standard Control Organization, or CDSCO. The Central…
Read More